Oppenheimer downgraded Zogenix, Inc. (NASDAQ: ZGNX) from Outperform to Perform after the company fails to win FDA panel backing for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE